Every med-device sales leader has had the same conversation with the same platform vendor: the demo shows beautiful territory maps, the contract lands at $25K to $140K a year, and the data underneath is six months old by the time you see it.
Six months in med-device sales is an eternity. Practices close, merge, change owners, switch device platforms, and hire new providers. A claims record from last quarter says what an account was doing. It doesn't say what's happening now, and it definitely doesn't say who's ready to buy.
The legacy data model
Legacy platforms built their business on CMS claims data and provider registries. That data is real, it's just stale and generic. It tells you a practice exists. It doesn't tell you whether that practice fits your product line, whether the right providers are in the building, or whether there's a competitor device installed that you could be replacing.
The result: reps pay six figures for a list that still requires them to do all the discovery work themselves.
What real-time intelligence looks like
Fathom scores accounts against your actual product line and ideal buyer profile, not a generic provider taxonomy. The platform combines live web data, verified install bases, and AI scoring to rank accounts by fit and readiness. The rep doesn't get a spreadsheet of practices. They get a ranked list of accounts that are likely to buy, and a brief on why each one fits.
The install base data matters more than most leaders realize. If you know exactly where competitor devices are installed and where they're aging, you know where the replacement opportunity is. That's territory intelligence, not a directory.
The math on switching
A $60K a year legacy contract buys you stale claims and a login. The same money across your sales force buys real-time scoring on every account in your territory, briefs your reps can walk in with, and coverage of the accounts the legacy platforms never had structured data for at all.
For a company like Tiger Aesthetics, the switch produced 225 net new accounts in a single quarter after a year with zero. The legacy platform never would have found those accounts, because it was looking at the same six-month-old list everyone else had.
The bottom line
The data trap isn't the price. It's the confidence. Reps trust the ranked list in front of them, so they stop double-checking and start calling. When the intelligence is real-time and specific to your product line, the whole territory opens up.
See the full breakdown of how Fathom compares to legacy claims-data platforms here.